Malaria Archives -

Geopolitical-uncertainty-grips-digital-health-investors

Researchers have found that an alcohol support group, such as Alcoholics Anonymous, when combined with other treatments is

New trends in the treatment of diseases

https://pharmaphorum.com/news/new-trends-in-the-treatment-of-diseases/

Market Access/ News/ News/ News/ Patients

GSK pledges £1bn drive for infectious disease R&D

Phil Taylor developing countries, GlaxoSmithKline, HIV, infectious diseases, Malaria, Novartis, patients, tropical diseases, tuberculosis 0 Comment

GSK will invest around £1 billion ($1.2 billion) over a 10-year period to speed up R&D on infectious

GSK pledges £1bn drive for infectious disease R&D

https://pharmaphorum.com/news/gsk-pledges-1bn-drive-for-infectious-disease-rd/

News/ News/ Patients

GSK’s malaria vaccine gets WHO okay for mass rollout

Phil Taylor GlaxoSmithKline, infectious disease, Malaria, parasitology, vaccine, World Health Organisation 0 Comment

The WHO has given a green light to widespread use of GlaxoSmithKline’s malaria vaccine in Africa, in what

GSK’s malaria vaccine gets WHO okay for mass rollout

https://pharmaphorum.com/news/gsks-malaria-vaccine-gets-who-okay-for-mass-rollout/

News/ News/ R&D

Novartis drug raises hope of tackling malaria drug resistance

Phil Taylor Coartem, ganaplacide, infectious disease, Malaria, Novartis, parasitology 0 Comment

More than two decades ago , Novartis made a big contribution to the fight against malaria when it

Novartis drug raises hope of tackling malaria drug resistance

https://pharmaphorum.com/news/novartis-drug-raises-hope-of-tackling-malaria-drug-resistance/

News/ News/ R&D

More malaria hope as NIH antibody protects against infection

Phil Taylor antibody, infectious disease, Malaria, NIAID, NIH, parasitology, R&D 0 Comment

A single dose of a monoclonal antibody developed by scientists at the US National Institutes of Health (NIH)

More malaria hope as NIH antibody protects against infection

https://pharmaphorum.com/news/more-malaria-hope-as-antibody-protects-against-infection/

News/ News/ R&D

BioNTech’s mRNA vaccine drive now includes malaria, TB shots

Phil Taylor BioNTech, Malaria, mRNA, tuberculosis, vaccines 0 Comment

Flushed with the success of its COVID-19 vaccine, BioNTech has pressed the accelerator on the development of shots

BioNTech’s mRNA vaccine drive now includes malaria, TB shots

https://pharmaphorum.com/news/biontechs-mrna-vaccine-drive-now-includes-malaria-tb-shots/

News/ News/ R&D

Oxford’s malaria shot set for phase 3 test after ‘unprecedented’ 77% efficacy

Richard Staines infectious diseases, Malaria, R&D, vaccine 0 Comment

Following the success of the coronavirus vaccine developed with AstraZeneca, Oxford University’s Jenner Institute has unveiled trial results

Oxford’s malaria shot set for phase 3 test after ‘unprecedented’ 77% efficacy

https://pharmaphorum.com/news/oxfords-malaria-shot-set-for-phase-3-test-after-unprecedented-77-efficacy/

News/ News/ R&D

Tafenoquine – single shot malaria cure endorsed by the FDA advisers

Piotr Wnuk GSK, Malaria, Tafenoquine 0 Comment

The US Food and Drugs Administration Advisory Committee has endorsed tafenoquine, a single-dose drug from the GSK pipeline

Tafenoquine – single shot malaria cure endorsed by the FDA advisers

https://pharmaphorum.com/news/tafenoquine-single-shot-malaria-cure-endorsed-by-the-fda/

News/ News/ R&D/ Top stories/ US

Bill and Melinda Gates start not-for-profit biotech

Richard Staines Bill and Melinda Gates Medical Research Institute, Bill Gates, Biotech, diarrhoea, Gates Foundation, infectious diseases, Malaria, tuberculosis 0 Comment

Biotech will focus on diseases such as TB

Bill and Melinda Gates start not-for-profit biotech

https://pharmaphorum.com/news/gates-medical-research-institute-biotech/

Trending

Malaria

Login